Switches between biologics in patients with moderate‐to‐severe psoriasis: results from the French cohort PSOBIOTEQ

BACKGROUND: Biologics are the cornerstone of treatment of patients with moderate‐to‐severe plaque psoriasis and switches between biologics are frequently needed to maintain clinical improvement over time. OBJECTIVES: The main purpose of this study was to describe precisely switches between biologics...

Descripción completa

Detalles Bibliográficos
Autores principales: Curmin, R., Guillo, S., De Rycke, Y., Bachelez, H., Beylot‐Barry, M., Beneton, N., Chosidow, O., Dupuy, A., Joly, P., Jullien, D., Richard, M.A., Viguier, M., Sbidian, E., Paul, C., Mahé, E., Tubach, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796114/
https://www.ncbi.nlm.nih.gov/pubmed/35793473
http://dx.doi.org/10.1111/jdv.18409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796114/
https://www.ncbi.nlm.nih.gov/pubmed/35793473
http://dx.doi.org/10.1111/jdv.18409

Ejemplares similares